Avadel Pharmaceuticals PE Ratio 2006-2020 | AVDL

Current and historical p/e ratio for Avadel Pharmaceuticals (AVDL) from 2006 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Avadel Pharmaceuticals PE ratio as of September 30, 2020 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Avadel Pharmaceuticals PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-09-30 5.04 31.50
2020-06-30 8.08 $0.16 50.50
2020-03-31 7.94 $-0.56 0.00
2019-12-31 7.55 $-0.89 0.00
2019-09-30 4.16 $-2.54 0.00
2019-06-30 2.89 $-2.73 0.00
2019-03-31 1.44 $-2.59 0.00
2018-12-31 2.58 $-2.56 0.00
2018-09-30 4.39 $-1.08 0.00
2018-06-30 6.13 $-0.13 0.00
2018-03-31 7.29 $0.64 11.39
2017-12-31 8.20 $1.55 5.29
2017-09-30 10.50 $1.90 5.53
2017-06-30 11.03 $0.84 13.13
2017-03-31 9.68 $-0.32 0.00
2016-12-31 10.39 $-1.06 0.00
2016-09-30 12.40 $0.58 21.38
2016-06-30 10.74 $0.39 27.54
2016-03-31 11.04 $0.44 25.09
2015-12-31 12.21 $0.86 14.20
2015-09-30 16.31 $-1.58 0.00
2015-06-30 21.19 $-1.11 0.00
2015-03-31 17.98 $-1.23 0.00
2014-12-31 17.13 $-2.44 0.00
2014-09-30 14.31 $-1.55 0.00
2014-06-30 15.00 $-1.54 0.00
2014-03-31 13.40 $-2.28 0.00
2013-12-31 8.05 $-1.69 0.00
2013-09-30 6.56 $-1.53 0.00
2013-06-30 6.14 $-1.54 0.00
2013-03-31 4.30 $-0.30 0.00
2012-12-31 3.03 $-0.14 0.00
2012-09-30 4.09 $-0.58 0.00
2012-06-30 4.40 $-0.25 0.00
2012-03-31 5.13 $-0.34 0.00
2011-12-31 5.21 $-0.35 0.00
2011-09-30 4.17 $-0.16 0.00
2011-06-30 5.35 $-0.37 0.00
2011-03-31 6.01 $-0.41 0.00
2010-12-31 6.84 $-0.38 0.00
2010-09-30 7.24 $-0.72 0.00
2010-06-30 6.96 $-0.72 0.00
2010-03-31 8.57 $-0.69 0.00
2009-12-31 7.40 $-0.47 0.00
2009-09-30 8.76 $-0.35 0.00
2009-06-30 7.00 $-0.31 0.00
2009-03-31 6.00 $-0.30 0.00
2008-12-31 3.92 $-0.50 0.00
2008-09-30 7.32 $-0.62 0.00
2008-06-30 10.01 $-0.90 0.00
2008-03-31 9.32 $-1.33 0.00
2007-12-31 9.98 $-1.56 0.00
2007-09-30 8.99 $-1.58 0.00
2007-06-30 20.97 $-1.63 0.00
2007-03-31 25.60 $-1.46 0.00
2006-12-31 29.95 $-1.49 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.192B $0.059B
Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.202B 43.91
Takeda Pharmaceutical (TAK) Japan $57.191B 9.97
Astellas Pharma (ALPMY) Japan $28.020B 14.20
Eisai (ESALY) Japan $26.847B 22.69
UCB SA (UCBJF) Belgium $22.660B 0.00
Merck (MKGAF) Germany $18.934B 24.83
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $14.015B 45.56
Grifols, S.A (GRFS) Spain $11.558B 14.13
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $9.111B 35.27
IPSEN SA ADR (IPSEY) France $8.650B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.931B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.750B 12.82
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Orion OYJ (ORINY) Finland $7.077B 24.56
Ionis Pharmaceuticals (IONS) United States $6.773B 42.90
United Therapeutics (UTHR) United States $4.487B 10.37
Arrowhead Pharmaceuticals (ARWR) United States $4.442B 0.00
Evotec AG (EVTCY) Germany $3.927B 136.32
FibroGen (FGEN) United States $3.761B 0.00
ChemoCentryx (CCXI) United States $3.688B 0.00
Hypermarcas (HYPMY) Brazil $3.313B 12.19
PTC Therapeutics (PTCT) United States $3.200B 0.00
Sage Therapeutics (SAGE) United States $3.101B 0.00
Nektar Therapeutics (NKTR) United States $3.022B 0.00
Pacira BioSciences (PCRX) United States $2.538B 66.73
Xencor (XNCR) United States $2.242B 0.00
Revolution Medicines (RVMD) United States $2.240B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.086B 10.10
Corcept Therapeutics (CORT) United States $2.028B 18.67
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.838B 0.00
Cronos Group (CRON) Canada $1.767B 0.00
USANA Health Sciences (USNA) United States $1.522B 14.34
Ironwood Pharmaceuticals (IRWD) United States $1.507B 10.47
Heron Therapeutics (HRTX) United States $1.348B 0.00
Trillium Therapeutics (TRIL) Canada $1.333B 0.00
Indivior (INVVY) United States $1.185B 14.69
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.154B 11.00
Karyopharm Therapeutics (KPTI) United States $1.072B 0.00
Esperion Therapeutics (ESPR) United States $1.042B 0.00
Translate Bio (TBIO) United States $1.011B 0.00
Zogenix (ZGNX) United States $0.995B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.991B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.964B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.900B 560.38
Vectura Group (VEGPF) United Kingdom $0.828B 0.00
Endo (ENDP) Ireland $0.752B 1.11
VAXART, INC (VXRT) United States $0.745B 0.00
Collegium Pharmaceutical (COLL) United States $0.686B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.677B 0.00
ImmunoGen (IMGN) United States $0.621B 0.00
Tilray (TLRY) Canada $0.614B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.609B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.561B 0.00
Siga Technologies (SIGA) United States $0.548B 58.42
Aerie Pharmaceuticals (AERI) United States $0.532B 0.00
Molecular Templates (MTEM) United States $0.524B 0.00
Radius Health (RDUS) United States $0.518B 0.00
Flexion Therapeutics (FLXN) United States $0.513B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.496B 0.00
Ocular Therapeutix (OCUL) United States $0.492B 0.00
Ardelyx (ARDX) United States $0.472B 0.00
TherapeuticsMD (TXMD) United States $0.438B 0.00
Altimmune (ALT) United States $0.428B 0.00
Organogenesis Holdings (ORGO) United States $0.409B 0.00
Harpoon Therapeutics (HARP) United States $0.404B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.387B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.386B 19.27
Redhill Biopharma (RDHL) Israel $0.361B 0.00
MEI Pharma (MEIP) United States $0.354B 0.00
DURECT (DRRX) United States $0.351B 0.00
Akebia Therapeutics (AKBA) United States $0.343B 0.00
PROFOUND MEDICL (PROF) Canada $0.337B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.332B 8.23
IMV INC (IMV) Canada $0.309B 0.00
Innate Pharma SA (IPHYF) France $0.298B 0.00
Concert Pharmaceuticals (CNCE) United States $0.286B 0.00
Jounce Therapeutics (JNCE) United States $0.280B 13.26
Menlo Therapeutics (VYNE) United States $0.277B 0.00
Xeris Pharmaceuticals (XERS) United States $0.270B 0.00
Rafael Holdings (RFL) United States $0.259B 0.00
Calithera Biosciences (CALA) United States $0.243B 0.00
Lannett Co Inc (LCI) United States $0.239B 5.56
KalVista Pharmaceuticals (KALV) United States $0.226B 0.00
Nature's Sunshine Products (NATR) United States $0.223B 21.96
Oasmia Pharmaceutical AB (OASMY) Sweden $0.206B 0.00
Nivalis Therapeutics (ALPN) United States $0.205B 0.00
CASI Pharmaceuticals (CASI) United States $0.192B 0.00
Heat Biologics (HTBX) United States $0.183B 0.00
Otonomy (OTIC) United States $0.180B 0.00
OptiNose (OPTN) United States $0.176B 0.00
Taiwan Liposome (TLC) Taiwan $0.169B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.161B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.156B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.153B 0.00
Aquestive Therapeutics (AQST) United States $0.148B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.140B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.138B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.129B 0.00
Champions Oncology (CSBR) United States $0.118B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.112B 0.00
Aclaris Therapeutics (ACRS) United States $0.109B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.109B 0.00
MediWound (MDWD) Israel $0.104B 0.00
Lipocine (LPCN) United States $0.091B 0.00
Biomerica (BMRA) United States $0.084B 0.00
Hemispherx BioPharma (AIM) United States $0.084B 0.00
CTI BioPharma (CTIC) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.073B 0.00
ElectroCore (ECOR) United States $0.073B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.072B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.071B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.069B 0.00
Infinity Pharmaceuticals (INFI) United States $0.068B 0.00
Novan (NOVN) United States $0.067B 0.00
Addex Therapeutics (ADXN) Switzerland $0.066B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.059B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.057B 0.00
CV Sciences (CVSI) United States $0.055B 0.00
Recro Pharma (REPH) United States $0.050B 0.00
Onconova Therapeutics (ONTX) United States $0.050B 0.00
Natural Alternatives (NAII) United States $0.049B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 29.09
SCYNEXIS (SCYX) United States $0.046B 0.00
India Globalization Capital (IGC) United States $0.045B 0.00
ProPhase Labs (PRPH) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
IsoRay (ISR) United States $0.040B 0.00
PolarityTE (PTE) United States $0.040B 0.00
GTx (ONCT) United States $0.035B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.96
Bellicum Pharmaceuticals (BLCM) United States $0.034B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.032B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.031B 0.00
AgeX Therapeutics (AGE) United States $0.030B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.029B 0.00
Neos Therapeutics (NEOS) United States $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
Vical (BBI) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.024B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
Sundial Growers (SNDL) Canada $0.020B 0.00
Regulus Therapeutics (RGLS) United States $0.020B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Bio-Path Holdings (BPTH) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.016B 23.64
Iterum Therapeutics (ITRM) Ireland $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
JanOne (JAN) United States $0.009B 0.00
China SXT Pharmaceuticals (SXTC) China $0.009B 0.00
Shineco (TYHT) China $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00